| Overview |
| bsm-62257r-Cy5.5-100ul |
| IL-27beta Recombinant Antibody, Cy5.5 Conjugated |
| WB |
| Human, Mouse, Rat |
| Specifications |
| Cy5.5 |
| Rabbit |
| KLH conjugated synthetic peptide derived from human IL 27B |
| Recombinant |
| IgG |
| Lot dependent |
| Purified by Protein A. |
| Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target |
| 10148 |
| Q14213 |
| EBI3; IL-27B; IL27 subunit beta; IL27B; interleukin 27 subunit beta. |
| Associates with IL27 to form the IL-27 interleukin, a heterodimeric cytokine which functions in innate immunity. IL-27 has pro- and anti-inflammatory properties, that can regulate T-helper cell development, suppress T-cell proliferation, stimulate cytotoxic T-cell activity, induce isotype switching in B-cells, and that has diverse effects on innate immune cells. |
| Application Dilution |
| WB |
1:300-5000 |
Powered by Bioz